A lab model shows how glioblastoma cells learn to resist treatment
Original title: Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done with tumor cells grown in a lab.
The short version
Scientists built a lab tool to study why glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary treatment stops working.
What was studied. Researchers grew stem-like tumor cells from glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary in the lab. They treated some with the drug temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary, some with radiation, and some not at all.
What they found. Tumor cells that survived the drug became harder to kill. Cells that lived through radiation got better at fixing their own DNA. Both groups picked up changes in their chromosomes and stronger growth signals.
What this means, and what it doesn't
What it could mean: This is a research tool, not a treatment. It may help scientists learn why drugs and radiation stop working over time. That could help others design better treatments down the road.
What it doesn't mean: This work was done with cells in a dish, not in people. No patient was treated or helped in this study. It does not change the care a doctor can give you today. It is not a cure, and it is not a promise of one.
Source: PubMed, November 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.